Eliminating HIV/HCV co-infection in gay and bisexual men: is it achievable through scaling up treatment?

References

• Platt L, Easterbrook P, Gower E, et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):797–808. Epub 2016/02/29. PubMed PMID: 26922272.
   PubMed Web of Science ®Google Scholar
• Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. The Lancet. 2014;384(9939):241–248.
   PubMed Web of Science ®Google Scholar
• Mahony AA, Donnan EJ, Lester RA, et al. Beyond injecting drug use: investigation of a Victorian cluster of hepatitis C among HIV-infected men who have sex with men. Med J Aust. 2013;198(4):210–214. Epub 2013/ 03/05. PubMed PMID: 23451966.
   PubMed Web of Science ®Google Scholar
• Hegazi A, Lee MJ, Whittaker W, et al. Chemsex and the city: sexualised substance use in gay bisexual and other men who have sex with men attending sexual health clinics. Int J STD AIDS. 2017;28(4):362–366. Epub 2016/ 05/15. PubMed PMID: 27178067.
   PubMed Web of Science ®Google Scholar
• Doyle JS, Aspinall E, Liew D, et al. Current and emerging antiviral treatments for hepatitis C infection. Br J Clin Pharmacol. 2013;75(4):931–943. Epub 2012/08/14.
   PubMed Web of Science ®Google Scholar
• Martin NK, Hickman M, Hutchinson SJ, et al. Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis. 2013;57(Suppl 2):S39–45. Epub 2013/ 08/02.
   PubMedGoogle Scholar
• Martin NK, Thornton A, Hickman M, et al. Can hepatitis C virus (HCV) direct-acting antiviral treatment as prevention reverse the hcv epidemic among men who have sex with men in the United Kingdom? Epidemiological and modeling insights. Clin Infect Dis. 2016;62(9):1072–1080.
   PubMed Web of Science ®Google Scholar
• Lazarus JV, Wiktor S, Colombo M, et al. Micro-elimination - A path to global elimination of hepatitis C. J Hepatol. 2017;67(4):665–666.
   PubMed Web of Science ®Google Scholar
• UNAIDS. Global AIDS update 2016. Geneva, Switzerland:UNAIDS; 2016.
   Google Scholar
• Taylor LE, Swan T, Matthews GV. Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of direct-acting antiviral-based therapy. Clin Infect Dis. 2013;57(Suppl 2):S118–24. Epub 2013/08/02.
   PubMedGoogle Scholar
• Janjua NZ, Kuo M, Yu A, et al. The population level cascade of care for hepatitis C in British Columbia, Canada: the BC Hepatitis Testers Cohort (BC-HTC). EBioMedicine. 2016;12:189–195. Epub 2016/ 10/26. PubMed PMID: 27596150; PubMed Central PMCID: PMCPMC5078584.
   PubMed Web of Science ®Google Scholar
• Dowdle WR. The principles of disease elimination and eradication. Bull World Health Organ. 1998;76(Suppl 2):22–25. PubMed PMID: PMC2305684.
   PubMedGoogle Scholar
• Hopkins DR. Disease eradication. N Engl J Med. 2013;3681:54–63. PubMed PMID: 23281976.
   PubMed Web of Science ®Google Scholar
• Zahnd C, Salazar-Vizcaya L, Dufour J-F, et al. Modelling the impact of deferring HCV treatment on liver-related complications in HIV coinfected men who have sex with men. J Hepatol. 2016;65(1):26–32.
   PubMed Web of Science ®Google Scholar
• Salazar Vizcaya L, Kouyos RD, Zahnd C, et al. Hepatitis C virus transmission among human immunodeficiency virus infected men who have sex with men: modeling the effect of behavioral and treatment interventions. Hepatology (Baltimore, Md). 2016;64(6):1856–1869. PubMed PMID: PMC5132019.
   PubMed Web of Science ®Google Scholar
• Virlogeux V, Zoulim F, Pugliese P, et al. Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination. BMC Med. 2017;15(1):217.
   PubMedGoogle Scholar
• Scott N, Stoove M, Wilson D, et al. Eliminating hepatitis C virus as a public health threat among HIV-positive men who have sex with men: a multi-modelling approach to understand differences in sexual risk behaviour. J Int AIDS Soc. 2018;21(1):e25059. PubMed PMID: 29314670; PubMed Central PMCID: PMC5810343.
   Web of Science ®Google Scholar
• Wandeler G, Gsponer T, Bregenzer A, et al. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clin Infect Dis. 2012;55(10):1408–1416.
   PubMed Web of Science ®Google Scholar
• Witt MD, Seaberg EC, Darilay A, et al. Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984-2011. Clin Infect Dis. 2013;57(1):77–84. Epub 2013/ 03/28. PubMed PMID: 23532480; PubMed Central PMCID: PMC3669529.
   PubMed Web of Science ®Google Scholar
• Vanhommerig JW, Stolte IG, Lambers FA, et al. Stabilizing incidence of hepatitis C virus infection among men who have sex with men in Amsterdam. J Acquir Immune Defic Syndr. 2014;66(5):e111–5. Epub 2014/05/24. PubMed PMID: 24853305.
   PubMed Web of Science ®Google Scholar
• van Santen DK, van der Helm JJ, Del Amo J, et al. Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990–2014. J Hepatol. 2017;67(2):255–262.
   PubMed Web of Science ®Google Scholar
• Hagan H, Jordan AE, Neurer J, et al. Incidence of sexually-transmitted hepatitis C virus infection in HIV-positive men who have sex with men: a systematic review and meta-analysis. AIDS (London, England). 2015;29(17):2335–2345. PubMed PMID: PMC4640945.
   PubMed Web of Science ®Google Scholar
• Ghisla V, Scherrer AU, Nicca D, et al. Incidence of hepatitis C in HIV positive and negative men who have sex with men 2000–2016: a systematic review and meta-analysis. Infection. 2017;45(3):309–321.
   PubMed Web of Science ®Google Scholar
• van de Laar T, Pybus O, Bruisten S, et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology. 2009;136(5):1609–1617.
   PubMed Web of Science ®Google Scholar
• Matthews GV, Pham ST, Hellard M, et al. Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C. Clin Infect Dis. 2011;52(6):803–811. Epub 2011/02/02. PubMed PMID: 21282185; PubMed Central PMCID: PMCPMC3106259.
   PubMed Web of Science ®Google Scholar
• Vanhommerig JW, Lambers FA, Schinkel J, et al. Risk factors for sexual transmission of hepatitis C virus among human immunodeficiency virus-infected men who have sex with men: a case-control study. Open Forum Infect Dis. 2015;2(3):ofv115. Epub 2015/ 12/04. PubMed PMID: 26634219; PubMed Central PMCID: PMCPMC4665384.
   PubMed Web of Science ®Google Scholar
• Danta M, Brown D, Bhagani S, et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS. 2007;21(8):983–991. Epub 2007/04/26. PubMed PMID: 17457092.
   PubMed Web of Science ®Google Scholar
• Schmidt AJ, Rockstroh JK, Vogel M, et al. Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany–a case-control study. PLoS One. 2011;6(3):e17781. Epub 2011/ 03/17. PubMed PMID: 21408083; PubMed Central PMCID: PMCPMC3050932.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men–New York City, 2005-2010. MMWR Morb Mortal Wkly Rep. 2011;60(28):945–950. Epub 2011/07/22. PubMed PMID: 21775948.
   PubMedGoogle Scholar
• Urbanus AT, van de Laar TJ, Geskus R, et al. Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995-2010. Aids. 2014;28(5):781–790. Epub 2014/05/17. PubMed PMID: 24832014.
   PubMed Web of Science ®Google Scholar
• Jin F, Matthews GV, Grulich AE. Sexual transmission of hepatitis C virus among gay and bisexual men: a systematic review. Sex Health. 2017;14(1):28–41. Epub 2016/ 10/08. PubMed PMID: 27712618.
   PubMed Web of Science ®Google Scholar
• Steininger K, Boyd A, Dupke S, et al. HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C. J Viral Hepat. 2017;24(10):832–839. Epub 2017/04/26. PubMed PMID: 28439936.
   PubMed Web of Science ®Google Scholar
• Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat. 2006;13(1):34–41.
   PubMed Web of Science ®Google Scholar
• Zhang M, Rosenberg PS, Brown DL, et al. Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. Blood. 2006;107(3):892–897. Epub 2005/ 10/06. PubMed PMID: 16204310; PubMed Central PMCID: PMC1895891.
   PubMed Web of Science ®Google Scholar
• Grebely J, Page K, Sacks-Davis R, et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014;59(1):109–120. Epub 2013/ 08/03. PubMed PMID: 23908124; PubMed Central PMCID: PMC3972017.
   PubMed Web of Science ®Google Scholar
• Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009;461(7265):798–801. Epub 2009/ 09/18. PubMed PMID: 19759533.
   PubMed Web of Science ®Google Scholar
• Post JJ, Pan Y, Freeman AJ, et al. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. J Infect Dis. 2004;189(10):1846–1855. Epub 2004/05/04. PubMed PMID: 15122521.
   PubMed Web of Science ®Google Scholar
• Takaki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 2000;6(5):578–582. Epub 2000/05/10. PubMed PMID: 10802716.
   PubMed Web of Science ®Google Scholar
• Osburn WO, Snider AE, Wells BL, et al. Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses. Hepatology. 2014;59(6):2140–2151. Epub 2014/01/16. PubMed PMID: 24425349; PubMed Central PMCID: PMCPMC4043926.
   PubMed Web of Science ®Google Scholar
• Smith DJ, Jordan AE, Frank M, et al. Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis. BMC Infect Dis. 2016;16:471. Epub 2016/09/07. PubMed PMID: 27595855; PubMed Central PMCID: PMCPMC5011802.
   PubMed Web of Science ®Google Scholar
• Seaberg EC, Witt MD, Jacobson LP, et al. Spontaneous clearance of the hepatitis C virus among men who have sex with men. Clin Infect Dis. 2015;61(9):1381–1388. Epub 2015/07/16. PubMed PMID: 26175521; PubMed Central PMCID: PMCPMC4599393.
   PubMed Web of Science ®Google Scholar
• Newsum AM, Schinkel J, van de Laar TJW, et al. Spontaneous clearance of hepatitis C virus infection among human immunodeficiency virus–infected men who have sex with men. Open Forum Infect Dis. 2017;4(2):ofx090. PubMed PMID: PMC5473437
   PubMed Web of Science ®Google Scholar
• Ingiliz P, Martin TC, Rodger A, et al. HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe. J Hepatol. 2017;66(2):282–287. PubMed PMID: WOS:000393261200005.
   PubMed Web of Science ®Google Scholar
• Thomson EC, Fleming VM, Main J, et al. Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut. 2010. Epub 2010/ 12/09. DOI:10.1136/gut.2010.217166 PubMed PMID: 21139063.
   PubMed Web of Science ®Google Scholar
• Martin TCS, Martin NK, Hickman M, et al. HCV reinfection incidence and treatment outcome among HIV-positive MSM in London. AIDS. 2013 ;27(16):2551-2557.
   Google Scholar
• Ingiliz P, Steininger K, Schuetze M, et al. Acute hepatitis C virus (HCV) infection in the setting of HIV coinfection: a single-centre 10-year follow-up. J Int AIDS Soc. 2014;17(4 Suppl 3):19638. Epub 2014/ 11/14. PubMed PMID: 25394142; PubMed Central PMCID: PMCPMC4224944.
   PubMedGoogle Scholar
• Ishikane M, Watanabe K, Tsukada K, et al. Acute hepatitis C in HIV-1 infected Japanese Cohort: single center retrospective cohort study. PLoS One. 2014;9(6):e100517. Epub 2014/ 06/20. PubMed PMID: 24945812; PubMed Central PMCID: PMCPMC4063971.
   PubMed Web of Science ®Google Scholar
• Flynn JK, Dore GJ, Matthews G, et al. Impaired hepatitis C virus (HCV)-specific interferon-gamma responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts. J Infect Dis. 2012;206(10):1568–1576. Epub 2012/ 09/06. PubMed PMID: 22949308; PubMed Central PMCID: PMCPMC3475632.
   PubMed Web of Science ®Google Scholar
• Thomson EC, Nastouli E, Main J, et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS (London, England). 2009;23(1):89–93. PubMed PMID: PMC2646374.
   PubMed Web of Science ®Google Scholar
• Ragonnet R, Deuffic-Burban S, Boesecke C, et al. Estimating the time to diagnosis and the chance of spontaneous clearance during acute hepatitis C in human immunodeficiency virus-infected individuals. Open Forum Infect Dis. 2017;4(1):ofw235. Epub 2017/05/10. PubMed PMID: 28480234; PubMed Central PMCID: PMCPMC5414115.
   PubMed Web of Science ®Google Scholar
• Vispo E, Barreiro P, Plaza Z, et al. Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy. AIDS. 2014;28(10):1473–1478. Epub 2014/03/19. PubMed PMID: 24637541.
   PubMed Web of Science ®Google Scholar
• Stenkvist J, Nystrom J, Falconer K, et al. Occasional spontaneous clearance of chronic hepatitis C virus in HIV-infected individuals. J Hepatol. 2014;61(4):957–961. Epub 2014/06/22. PubMed PMID: 24951853.
   PubMed Web of Science ®Google Scholar
• Vogel M, Deterding K, Wiegand J, et al. Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals—experience from 2 large German networks on the study of acute HCV infection. Clin Infect Dis. 2009;49(2):317–319.
   PubMed Web of Science ®Google Scholar
• Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001;33(4):562–569. Epub 2001/07/20. PubMed PMID: 11462196.
   PubMed Web of Science ®Google Scholar
• Thein -H-H, Yi Q, Dore GJ, et al. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS. 2008;2215:1979–1991. PubMed PMID: 00002030-200810010-00010.
   PubMed Web of Science ®Google Scholar
• Bottieau E, Apers L, Van Esbroeck M, et al. Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001-2009: Euro Surveill. 2010;15(39):19673.
   Google Scholar
• Fierer DS, Mullen MP, Dieterich DT, et al. Early-onset liver fibrosis due to primary hepatitis C virus infection is higher over time in HIV-infected men. Clin Infect Dis. 2012;55(6):887–888.
   PubMed Web of Science ®Google Scholar
• Fierer DS, Uriel AJ, Carriero DC, et al. Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis. 2008;198(5):683–686.
   PubMed Web of Science ®Google Scholar
• Vogel M, Page E, Boesecke C, et al. Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individuals. Clin Infect Dis. 2012;54(4):556–559. Epub 2011/12/14. PubMed PMID: 22156856.
   PubMed Web of Science ®Google Scholar
• Fierer DS, Dieterich DT, Fiel MI, et al. Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection. Clin Infect Dis. 2013;56(7):1038–1043. Epub 2012/ 12/25. PubMed PMID: 23264364; PubMed Central PMCID: PMCPMC3588118.
   PubMed Web of Science ®Google Scholar
• Bhattacharya D, Belperio PS, Shahoumian TA, et al. Effectiveness of all-oral antiviral regimens in 996 human immunodeficiency virus/hepatitis C virus genotype 1–coinfected patients treated in routine practice. Clin Infect Dis. 2017;64(12):1711–1720.
   PubMed Web of Science ®Google Scholar
• Naggie S, Cooper C, Saag M, et al. Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1. N Engl J Med. 2015;373(8):705–713.
   PubMed Web of Science ®Google Scholar
• Sulkowski MS, Eron JJ, Wyles D, et al. Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial. Jama. 2015;313(12):1223–1231.
   PubMed Web of Science ®Google Scholar
• Wyles D, Bräu N, Kottilil S, et al. Sofosbuvir and velpatasvir for the treatment of hcv in patients coinfected with hiv-1: an open-label, phase 3 study. Clin Infect Dis. 2017;65(1):6-12.
   Google Scholar
• Wyles DL, Ruane PJ, Sulkowski MS, et al. Daclatasvir plus sofosbuvir for HCV in patients coinfected with HIV-1. N Engl J Med. 2015;373(8):714–725.
   PubMed Web of Science ®Google Scholar
• Saeed S, Strumpf EC, Walmsley SL, et al. How generalizable are the results from trials of direct antiviral agents to people coinfected with HIV/HCV in the real world? Clin Infect Dis. 2016;62(7):919–926.
   PubMed Web of Science ®Google Scholar
• Neukam K, Morano-Amado LE, Rivero-Juárez A, et al. HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study. HIV Clin Trials. 2017;18(3):126–134.
   PubMed Web of Science ®Google Scholar
• Arias A, Aguilera A, Soriano V, et al. Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials. Antivir Ther. 2017;22(4):307–312. Epub 2016/ 06/25. PubMed PMID: 27341294.
   PubMed Web of Science ®Google Scholar
• Boesecke C, Ingiliz P, Berger F, et al. Liver cirrhosis as a risk factor for direct-acting antiviral therapy failure in real-life hepatitis C virus/human immunodeficiency virus coinfection. Open Forum Infect Dis. 2017;4(3):ofx158–ofx.
   PubMed Web of Science ®Google Scholar
• Bischoff J, Mauss S, Cordes C, et al. Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy? HIV Med. 2018;19(4):299-307. DOI:10.1111/hiv.12579
   Google Scholar
• Molina J-M, Orkin C, Iser DM, et al. Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study. The Lancet. 2015;385(9973):1098–1106.
   PubMed Web of Science ®Google Scholar
• Rockstroh JK, Nelson M, Katlama C, et al. Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial. The Lancet HIV. 2015;2(8):e319–e27.
   PubMed Web of Science ®Google Scholar
• Del Bello D, Cha A, Sorbera M, et al. Real-world sustained virologic response rates of sofosbuvir-containing regimens in patients coinfected with hepatitis C and HIV. Clin Infect Dis. 2016;62(12):1497–1504.
   PubMed Web of Science ®Google Scholar
• Hawkins C, Grant J, Ammerman LR, et al. High rates of hepatitis C virus (HCV) cure using direct-acting antivirals in HIV/HCV-coinfected patients: a real-world perspective. J Antimicrob Chemother. 2016;71(9):2642–2645.
   PubMed Web of Science ®Google Scholar
• Ingiliz P, Christensen S, Kimhofer T, et al. Sofosbuvir and ledipasvir for 8 weeks for the treatment of chronic hepatitis C virus (HCV) Infection in HCV-monoinfected and HIV-HCV-coinfected individuals: results from the German hepatitis C cohort (GECCO-01). Clin Infect Dis. 2016;63(10):1320–1324. Epub 2016/ 10/30. PubMed PMID: 27535952.
   PubMed Web of Science ®Google Scholar
• Mandorfer M, Schwabl P, Steiner S, et al. Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/HCV-coinfected patients with advanced liver disease. Z Gastroenterol. 2016;54(05):P60.
   Google Scholar
• Milazzo L, Lai A, Calvi E, et al. Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy. HIV Med. 2017;18(4):284–291.
   PubMed Web of Science ®Google Scholar
• Sogni P, Gilbert C, Lacombe K, et al. All-oral direct-acting antiviral regimens in HIV/hepatitis C virus–coinfected patients with cirrhosis are efficient and safe: real-life results from the prospective ANRS CO13–HEPAVIH cohort. Clin Infect Dis. 2016;63(6):763–770.
   PubMed Web of Science ®Google Scholar
• Naggie S, Fierer DS, Hughes M, et al., editors. 100% SVR with 8 weeks of ledipasvir/sofosbuvir in HIV-infected men with acute HCV infection: results from the SWIFT-C trial (Sofosbuvir-containing regimens without interferon for treatment of acute HCV in HIV-1 infected individuals). Hepatology. 2017;66:113A.
   Google Scholar
• Fierer DS, El Sayed A, Palaniswami P, editors. Sofosbuvir/ledipasvir in the treatment of early HCV infection in HIV-infected men. In: Hepatology. 2016; 64:992A.
   Google Scholar
• AASLD-IDSA. Recommendations for management of acute HCV infection. [ cited 2018 March6]. Available from: https://www.hcvguidelines.org/unique-populations/acute-infection
   Google Scholar
• EASL. Recommendations on treatment of hepatitis C. J Hepatol. 2016;66(1): 153–194.
   PubMedGoogle Scholar
• Rockstroh JK, Bhagani S, Hyland RH, et al. Ledipasvir-sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial. Lancet Gastroenterol Hepatol. 2017;2(5):347–353. Epub 2017/ 04/12. PubMed PMID: 28397698.
   PubMed Web of Science ®Google Scholar
• Martinello M, Gane E, Hellard M, et al. Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: the DARE-C II study. Hepatology. 2016;64(6):1911–1921. Epub 2016/10/28. PubMed PMID: 27639183.
   PubMed Web of Science ®Google Scholar
• Naggie S, Marks KM, Hughes M, et al. Sofosbuvir plus ribavirin without interferon for treatment of acute hepatitis C virus infection in HIV-1-infected individuals: SWIFT-C. Clin Infect Dis. 2017;64(8):1035–1042. Epub 2017/ 03/23. PubMed PMID: 28329053.
   PubMed Web of Science ®Google Scholar
• El Sayed A, Barbati ZR, Turner SS, et al. Sofosbuvir in the treatment of early HCV infection in HIV-infected men. HIV Clin Trials. 2017;18(2):60–66.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global hepatitis report 2017. Geneva; 2017. Contract No: Licence: CC BY-NC-SA 3.0 IGO.
   Google Scholar
• Marshall AD, Cunningham EB, Nielsen S, et al. Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe. Lancet Gastroenterol Hepatol. 2017. DOI:10.1016/S2468-1253(17)30284-4
   Web of Science ®Google Scholar
• Barua S, Greenwald R, Grebely J, et al. Restrictions for medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States. Ann Intern Med. 2015;163(3):215–223. PubMed PMID: 26120969.
   PubMed Web of Science ®Google Scholar
• Béguelin C, Suter A, Bernasconi E, et al. Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study. Liver Int. 2017;00:1–8.
   Google Scholar
• Chkhartishvili N, Abutidze A, Bolokadze N, et al. Hepatitis C care cascade for people living with HIV in the Country of Georgia. IAS 2017. Paris, France; 2017.
   Google Scholar
• Boerekamps A, van den Berk G, Lauw F, et al. Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy. Clin Infect Dis.
   Google Scholar
• Martinello M, Dore GJ, Bopage RI, et al., editors. DAA treatment scale-up in HIV/HCV co-infection: characterising a population at risk for reinfection. International Liver Congree (EASL); 2017 April; Amsterdam. J Hepatol. Vol. 66 S495-S496.
   Google Scholar
• Saris J, van den Berk G, Ait Moha D, et al. Successful implementation of HCV treatment in two large HIV clinics in Amsterdam: HCV treatment cascade of care. AIDS. 2017;31(12):1779–1780.
   PubMed Web of Science ®Google Scholar
• Béguelin C, Sutter A, Bernasconi E, et al., editors. Long-term trends in HCV treatment uptake, efficacy and liver disease in the SHCS. 2016 International congress on drug therapy in HIV infection; 2016; Glasgow.
   Google Scholar
• Pradat P, Huleux T, Raffi F, et al. Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV. AIDS (London, England). 2018;32(8):1077-1082.
   PubMedGoogle Scholar
• Saeed S, Strumpf EC, Moodie EEM, et al. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada. J Int AIDS Soc. 2017;20(3):e25013.
   PubMedGoogle Scholar
• Boerekamps A, Newsum AM, Smit C, et al. High treatment uptake in HIV/HCV-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands. Clin Infect Dis. 2017:cix1004–cix. DOI:10.1093/cid/cix1004
   Web of Science ®Google Scholar
• Ingiliz P, Christensen S, Berger F, et al., editors. HCV reinfection after successful DAA treatment: a GECCO analysis. Conference on retroviruses and opportunistic infections; Seattle, Washington. 2017.
   Google Scholar
• Simmons B, Saleem J, Hill A, et al. Risk of late relapse or reinfection with hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis. Clin Infect Dis. 2016;62(6):683–694. Epub 2016/ 01/21. PubMed PMID: 26787172; PubMed Central PMCID: PMCPMC4772843.
   PubMed Web of Science ®Google Scholar
• Lambers FA, Prins M, Thomas X, et al. Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS. 2011;25(17):F21–7. Epub 2011/08/23. PubMed PMID: 21857492.
   PubMed Web of Science ®Google Scholar
• Thomas XV, Grady BP, Van Der Meer JT, et al. Genetic characterization of multiple hepatitis C virus infections following acute infection in HIV-infected men who have sex with men. AIDS. 2015;29(17):2287–2295. Epub 2015/08/11. PubMed PMID: 26258527.
   PubMed Web of Science ®Google Scholar
• Martinello M, Grebely J, Petoumenos K, et al. HCV reinfection incidence among individuals treated for recent infection. J Viral Hepat. 2017;24(5):359–370. PubMed PMID: WOS:000399902800003.
   PubMed Web of Science ®Google Scholar
• Young J, Rossi C, Gill J, et al. Risk factors for hepatitis C virus reinfection after sustained virologic response in patients coinfected with HIV. Clin Infect Dis. 2017;64(9):1154–1162. Epub 2017/02/16. PubMed PMID: 28199495; PubMed Central PMCID: PMCPMC5399935.
   PubMed Web of Science ®Google Scholar
• Kurth AE, Spielberg F, Cleland CM, et al. Computerized counseling reduces HIV-1 viral load and sexual transmission risk: findings from a randomized controlled trial. J Acquir Immune Defic Syndr. 2014;65(5):611–620. Epub 2014/ 01/05. PubMed PMID: 24384803; PubMed Central PMCID: PMCPMC3999203.
   PubMed Web of Science ®Google Scholar
• Rotheram-Borus MJ, Swendeman D, Comulada WS, et al. Prevention for substance-using HIV-positive young people: telephone and in-person delivery. J Acquir Immune Defic Syndr. 2004;37(Suppl 2): S68–77. Epub 2004/ 09/24. PubMed PMID: 15385902; PubMed Central PMCID: PMCPMC2843590.
   PubMed Web of Science ®Google Scholar
• Johnson WD, Diaz RM, Flanders WD, et al. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men. Cochrane Database Syst Rev. 2008;(3). DOI:10.1002/14651858.CD001230.pub2 PubMed PMID: CD001230.
   Web of Science ®Google Scholar
• Pakianathan MR, Lee MJ, Kelly B, et al. How to assess gay, bisexual and other men who have sex with men for chemsex. Sex Transm Infect. 2016;92(8):568–570.
   PubMed Web of Science ®Google Scholar
• Scott N, Doyle J, Wilson DP, et al. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade. Int J Drug Policy. 2017;47:107–116.
   PubMed Web of Science ®Google Scholar
• Hoornenborg E, Achterbergh R, Schim Van Der Loeff M, et al. MSM starting pre-exposure prophylaxis are at risk of hepatitis C virus infection. AIDS. 2017;31:1603–1610. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• MacGregor L, Martin NK, Mukandavire C, et al. Behavioural, not biological, factors drive the HCV epidemic among HIV-positive MSM: HCV and HIV modelling analysis including HCV treatment-as-prevention impact. Int J Epidemiol. 2017;46(5):1582–1592. Epub 2017/ 06/13. PubMed PMID: 28605503.
   PubMed Web of Science ®Google Scholar
• Vogel M, van de Laar T, Kupfer B, et al. Phylogenetic analysis of acute hepatitis C virus genotype 4 infections among human immunodeficiency virus-positive men who have sex with men in Germany. Liver Int. 2010;30(8):1169–1172. Epub 2010/07/17. PubMed PMID: 20633101.
   PubMed Web of Science ®Google Scholar
• Bartlett SR, Jacka B, Bull RA, et al. HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection. Infection, Genet Evol. 2016;37:252–258.
   PubMed Web of Science ®Google Scholar
• Baral S, Sifakis F, Cleghorn F, et al. Elevated risk for hiv infection among men who have sex with men in low- and middle-income countries 2000–2006: a systematic review. PLoS Med. 2007;4(12):e339.
   PubMed Web of Science ®Google Scholar
• DeHovitz J, Uuskula A, El-Bassel N. The HIV epidemic in Eastern Europe and Central Asia. Curr HIV/AIDS Rep. 2014;11(2):168–176.
   PubMed Web of Science ®Google Scholar
• Beyrer C, Abdool Karim Q. The changing epidemiology of HIV in 2013. Curr Opin HIV AIDS. 2013;8(4):306–310. PubMed PMID: 01222929-201307000-00009.
   PubMed Web of Science ®Google Scholar
• Caceres C, Pecheny M, Frasca T, et al. Review of legal frameworks and the situation of human rights related to sexual diversity in low and middle income countries. Report commissioned by UNAIDS; 2008.
   Google Scholar